Mitomics Inks Sales and Marketing Deal with LabCorp | GenomeWeb

NEW YORK (GenomeWeb News) – Mitomics today announced a deal with Laboratory Corporation of America to offer Mitomics' molecular prostate cancer test.

Under the terms of the deal, urologists will be able to order Mitomics' Prostate Core Mitomic Test through Dianon Systems, LabCorp's specialized laboratory subsidiary focused on anatomic pathology. The test will be performed at Mitomics' CLIA laboratory in Aurora, Colo.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genome sequencing study of Yakutian horses, tardigrade genome, and more.

A guest post at Retraction Watch discusses what funders can do to improve research reproducibility.

Researchers report in Nature this week that farming led to genomic adaptations in humans.

The FDA argues that it needs to evaluate the safety and efficacy of laboratory-developed tests, a proposal that divides Republicans.